BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine.

Saved in:
Bibliographic Details
Title: BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine.
Authors: Perera DJ; Division of Experimental Medicine, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada., Domenech P; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; McGill International TB Centre, McGill University, Montréal, QC, Canada., Babuadze GG; Department of Biological Sciences, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.; Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA., Naghibosadat M; Department of Biological Sciences, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada., Alvarez F; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada., Koger-Pease C; Division of Experimental Medicine, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada., Labrie L; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada., Stuible M; Department of Production Platforms & Analytics, Human Health Therapeutics Research Center, National Research Council Canada, Montréal, QC, Canada., Durocher Y; Department of Production Platforms & Analytics, Human Health Therapeutics Research Center, National Research Council Canada, Montréal, QC, Canada., Piccirillo CA; Division of Experimental Medicine, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada., Lametti A; Department of Pathology, McGill University, Montréal, QC, Canada., Fiset PO; Department of Pathology, McGill University, Montréal, QC, Canada., Elahi SM; Department of Production Platforms & Analytics, Human Health Therapeutics Research Center, National Research Council Canada, Montréal, QC, Canada., Kobinger GP; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada., Gilbert R; Department of Production Platforms & Analytics, Human Health Therapeutics Research Center, National Research Council Canada, Montréal, QC, Canada., Olivier M; Division of Experimental Medicine, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada., Kozak R; Department of Biological Sciences, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.; Department of Laboratory Medicine and Molecular Diagnostics, Division of Microbiology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Reed MB; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; McGill International TB Centre, McGill University, Montréal, QC, Canada., Ndao M; Division of Experimental Medicine, McGill University, Montréal, QC, Canada.; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, QC, Canada.; National Reference Centre for Parasitology, McGill University Health Centre, Montréal, QC, Canada.
Source: IScience [iScience] 2023 Aug 11; Vol. 26 (9), pp. 107612. Date of Electronic Publication: 2023 Aug 11 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2023.107612